Evidence map›Paper›PMID 36220810›Full record

ArticleNature communications2022

Plasmonic high-entropy carbides.

Arrigo Calzolari, Corey Oses, Cormac Toher, Marco Esters, Xiomara Campilongo, Sergei P Stepanoff, Douglas E Wolfe, Stefano Curtarolo

Abstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Materials design for hypersonics.Nature communications · 2024
    Review
  3. Article
  4. Article
  5. Promises of Plasmonic Antenna-Reactor Systems in Gas-Phase COAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Arrigo CalzolariCNR-NANO Research Center S3, Modena, Italy. arrigo.calzolari@nano.cnr.it.ORCID http://orcid.org/0000-0002-0244-7717
Corey OsesDepartment of Mechanical Engineering and Materials Science, Duke University, Durham, NC, USA.ORCID http://orcid.org/0000-0002-3790-1377
Cormac ToherCenter for Autonomous Materials Design, Duke University, Durham, NC, USA.
Marco EstersDepartment of Mechanical Engineering and Materials Science, Duke University, Durham, NC, USA.ORCID http://orcid.org/0000-0002-8793-2200
Xiomara CampilongoCenter for Autonomous Materials Design, Duke University, Durham, NC, USA.ORCID http://orcid.org/0000-0001-6123-8117
Sergei P StepanoffApplied Research Laboratory, The Pennsylvania State University, University Park, PA, USA.
Douglas E WolfeApplied Research Laboratory, The Pennsylvania State University, University Park, PA, USA.
Stefano CurtaroloDepartment of Mechanical Engineering and Materials Science, Duke University, Durham, NC, USA. stefano@duke.edu.ORCID http://orcid.org/0000-0003-0570-8238

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Discovering multifunctional materials with tunable plasmonic properties, capable of surviving harsh environments is critical for advanced optical and telecommunication applications. We chose high-entropy transition-metal carbides because of their exceptional thermal, chemical stability, and mechanical properties. By integrating computational thermodynamic disorder modeling and time-dependent density functional theory characterization, we discovered a crossover energy in the infrared and visible range, corresponding to a metal-to-dielectric transition, exploitable for plasmonics. It was also found that the optical response of high-entropy carbides can be largely tuned from the near-IR to visible when changing the transition metal components and their concentration. By monitoring the electronic structures, we suggest rules for optimizing optical properties and designing tailored high-entropy ceramics. Experiments performed on the archetype carbide HfTa

Identifiers

PMID36220810
PMCPMC9553889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.